stockrowDr. Reddy's Laboratories Ltd (RDY) vs Takeda Pharmaceutical Co. (TAK)
- Dr. Reddy's Laboratories Ltd RDY 14.83 +2.06%
- Takeda Pharmaceutical Co. TAK 21.05 −0.66%
Dr. Reddy's Laboratories Ltd and Takeda Pharmaceutical Co. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $67.7B against $12.1B — 5.6× the size. Takeda Pharmaceutical Co. trades at the lower P/E: 32.0× against 44.4×. Takeda Pharmaceutical Co. grew revenue faster over the last twelve months: 0.66% against −15.5%. Dr. Reddy's Laboratories Ltd has the higher net margin (8.06% vs 7.12%) and the higher return on invested capital (4.77% vs 0.00%). Only Takeda Pharmaceutical Co. pays a dividend (1.45%). Across the 23 metrics below, Takeda Pharmaceutical Co. leads on 12 and Dr. Reddy's Laboratories Ltd on 11.
Valuation
Profitability
| Metric | RDY | TAK | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.16% | 65.85% | 53.51% |
| Operating margin | 9.20% | 11.61% | 0.00% |
| Net margin | 8.06% | 7.12% | (2.45%) |
| Free cash flow margin | 2.88% | 0.00% | 0.00% |
| Return on equity | 6.60% | 0.00% | (0.80%) |
| Return on assets | 4.44% | 0.00% | (1.67%) |
| Return on invested capital | 4.77% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack